Autoimmune disease is a kind of heterogeneous disease caused by the loss of immune tolerance to autoantigens.In recent years,antibody drug has become an important choice for the treatment of autoimmune diseases.Monoclonal antibodies are limited by their large relative molecular mass and difficult to penetrate solid tissues,while nanobodies,the smallest antibody fragment known to date with intact antigen recognition,have gained much attention in the treatment of autoimmune diseases due to their ease of modifi-cation,high penetration,and ability to target more cryptic epitopes.The review focuses on the application of nanobodies in the treat-ment of diseases such as rheumatoid arthritis,acquired thrombotic thrombocytopenic purpura,systemic lupus erythematosus,psoria-sis,and looks forward to the prospect of nanobodies in the treatment of autoimmune diseases.

The general data of 48.978 burn cases collected from 16 institutes and burn center in a period of 22 years (1958-1979) were analysed. It was found that the highest incidence of burns occurred in summer and before age of 30 (78.1%). particularly in the age group of 20-24 and under 5(22.97% and 22.95% respectively). Thermal burn was the commonest cause (89.57%). The ratio between female and male was 1:3. The ratio between cases with and without third degree burns was also 1:3. The burn extent was predominently under 30% TBSA (85.10%). cases with burn larger than 70% TBSA occupied less than 3% of the total. The exposed parts of the body. i.e. head, neck and limbs, were the prevalent areas affected. The mean hospitalization period was 26.9 days. The overall mortality rate was 4.93% and LA50 75.93%(Y = 7.5588-0.0337X). The incidences of shock and sepsis were 10.85% and 7.95% respectively. It was also found that the mortality rate (in terms of LA50). and incidences of both shock and sepsis have lowered remarkably (p